MetLife, Inc. (MET) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 2.68B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 6.56B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.68B | (m) | $6.56B | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $2.56B | (m) | $6.35B | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $2.44B | (m) | $6.14B | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $2.39B | (m) | $5.95B | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $2.33B | (m) | $5.74B | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $2.28B | (m) | $6.01B | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $2.25B | (m) | $6.00B | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $2.26B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $2.26B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $2.24B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $2.23B | (m) | $5.72B | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $2.11B | (m) | $5.98B | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $68.15B | $168.00M | (m) | (m) | (m) | 0.25% | (m) | (m) |
| 2011-12-31 | (m) | $70.26B | $144.00M | (m) | (m) | (m) | 0.20% | (m) | (m) |
| 2011-03-31 | (m) | $55.53B | (m) | (m) | $1.59B | (m) | (m) | (m) | Reported |
| 2010-12-31 | (m) | $52.72B | $84.00M | (m) | $1.55B | (m) | 0.16% | (m) | Reported |
| 2010-09-30 | (m) | $52.22B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | $50.02B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | $43.94B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $41.06B | $69.00M | (m) | $1.04B | (m) | 0.17% | (m) | Reported |
| 2009-09-30 | (m) | $42.68B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | $45.79B | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $50.98B | $123.00M | (m) | $1.05B | (m) | 0.24% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRUDENTIAL FINANCIAL INC (PRU) | United States | $40.974B | 9.56 |
| REINSURANCE GROUP OF AMERICA INC (RGA) | United States | $16.026B | 9.24 |
| Corebridge Financial, Inc. (CRBG) | United States | $15.196B | 14.06 |
| GLOBE LIFE INC. (GL) | United States | $12.862B | 13.60 |
| Jackson Financial Inc. (JXN) | United States | $8.813B | 67.77 |
| Voya Financial, Inc. (VOYA) | United States | $8.705B | 13.49 |
| Primerica, Inc. (PRI) | United States | $8.447B | 18.37 |
| LINCOLN NATIONAL CORP (LNC) | United States | $7.922B | 2.87 |
| GENWORTH FINANCIAL INC (GNW) | United States | $3.574B | 16.92 |
| Brighthouse Financial, Inc. (BHF) | United States | $3.075B | 4.35 |